Medherant

Manufacturing · United Kingdom · 11-50 Employees

View Company Info for Free

Overview

Headquarters

The Venture Centre University of Warwick...

Phone Number

+44 2476323060

Revenue

$5.1 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Medherant

Medherant is focused on developing innovative, sustainable transdermal drug delivery patches that enhance patient care. Their products specifically target women's health, pain management, and central nervous system (CNS) diseases. Utilizing their proprietary TEPI Patch technology, Medherant aims to provide greater convenience, confidence, and comfort for patients. The company seeks collaborations with partners for the development of transdermal or topical delivery systems leveraging this advanced technology.Explore more
Medherant's Social MediaPopular SearchesMedherant LtdMedherantSIC Code 28,283NAICS Code 32,325Show more

Is Medherant your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Medherant

Compare insights from companies similar to Medherant, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Medherant

$5.1M
11-50
Private
$17.7M
2014
N/A
$12.5M
11-50
Private
-
2005
$6.8M
11-50
Private
-
2000
TM
Timothy McIntyrePresident & CEO
$6M
11-50
Private
-
-
N/A
$5.4M
11-50
Private
-
1999
<$5M
1-10
Private
<$5M
2008
MB
Matthew BenardisVice President, Operations
<$5M
11-50
Private
<$5M
2007
RG
Rina GoldmanBrand Manager
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Medherant is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Medherant is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medherant.

Medherant financials insights

Gather financial insights about Medherant, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2016

Angel/Seed

$1.9M

2017

Multiple Rounds

$9.5M

2019

Corporate Investment

$2.5M

2023

Other Financing Round

$3.8M

See All Medherant's Financials Insights

Medherant Tech Stack

A closer look at the technologies used by Medherant

Medherant News & Media

  • Medherant Raises £3M in Funding

    Medherant, a Coventry, UK-based biotechnology company advancing a testosterone patch for women with menopausal symptoms, raised £3M in funding. Mercia Asset Management made the investment. The company intends to use the funds to accelerate its growth and research efforts. Led by CEO John Burt, Medherant is a clinical-stage company developing a testosterone replacement patch for […] The post Medherant Raises £3M in Funding appeared first on FinSMEs.
  • Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch® Technology

    CAMBRIDGE &amp; COVENTRY, England--(BUSINESS WIRE)--Cycle Pharmaceuticals Ltd (Cycle) and Medherant Ltd (Medherant) are pleased to announce that they have signed an agreement to develop and commercialize multiple products using the TEPI Patch® technology. Cycle will utilise Medherant’s proprietary TEPI Patch® transdermal delivery technology to develop formulations that will address patients’ unmet needs such as dysphagia and dyskinesia, further expanding its pipeline. Some of the benefits of the
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Medherant

What is Medherant's official website?
Medherant's official website is www.medherant.co.uk
What is Medherant's Revenue?
Medherant's revenue is $5.1 Million
What is Medherant's SIC code?
Medherant's SIC: 28,283
What is Medherant's NAICS code?
Medherant's NAICS: 32,325
How many employees does Medherant have?
Medherant has 11-50 employees
What industry does Medherant belong to?
Medherant is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Medherant competition?
Medherant top competitors include: Patchology, Vyteris, Cyrcadia Health, LAM Pharmaceutical
What technology does Medherant use?
Some of the popular technologies that Medherant uses are: WordPress.org, Drupal, PHP, Google Universal Analytics
How do I contact Medherant?
Medherant contact info: Phone number: +44 2476323060 Website: www.medherant.co.uk
What does Medherant do?

Medherant is focused on developing innovative, sustainable transdermal drug delivery patches that enhance patient care. Their products specifically target women's health, pain management, and central nervous system (CNS) diseases. Utilizing their proprietary TEPI Patch technology, Medherant aims to provide greater convenience, confidence, and comfo... rt for patients. The company seeks collaborations with partners for the development of transdermal or topical delivery systems leveraging this advanced technology.Read More

What are Medherant social media links?
Medherant Linkedin page Medherant Twitter page
Who invested in Medherant?
Medherant has 8 investors including Mercia Technologies PLC, Mercia Technologies PLC., Mercia Technologies and Mercia Fund Management.
Is Medherant a public company?
Medherant is private company therefore does not currently have an official ticker symbol
See more information about Medherant

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.